Watson Biotech said on an interactive platform on September 8 that the company's nine-valent HPV vaccine is currently in phase III clinical research. The company will advance the work related to vaccine products under development in accordance with the relevant national procedures and requirements for vaccine registration clinical trials. Please continue to pay attention to the company's subsequent disclosure announcements and regular reports for relevant information.

Watson Biotech said on an interactive platform on September 8 that the company's nine-valent HPV vaccine is currently in phase III clinical research. The company will advance the work related to vaccine products under development in accordance with the relevant national procedures and requirements for vaccine registration clinical trials. Please continue to pay attention to the company's subsequent disclosure announcements and regular reports for relevant information.